Is VRTX a good stock to buy? We came across a bullish thesis on Vertex Pharmaceuticals Incorporated on r/investing_discussion by Variant_Invest.
Keep Reading →
June 11 - News, Stock Analysis
Profitable stocks are getting more attention as investors focus on companies that can keep producing earnings even when rates, costs, and demand trends shift.
Keep Reading →
May 27 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2026 Earnings Call Transcript May 4, 2026Vertex Pharmaceuticals Incorporated beats earnings expectations.
Keep Reading →
May 5 - News, Transcripts
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the most profitable biotech stocks to buy now.
Keep Reading →
May 2 - News
Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, surpassing both the S&P 500 and the broader market index...
Keep Reading →
April 30 - Hedge Funds, News
TheFly reported on April 7 that RBC Capital Markets slightly increased its price target on VRTX from $541 to $543 while maintaining an Outperform rating.
Keep Reading →
April 24 - News
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more...
Keep Reading →
April 23 - Hedge Funds, News
In this article, we will look at Jim Cramer's recent stock calls on Mad Money.
Keep Reading →
April 20 - Hedge Funds, News
Even before tensions between Iran and the US picked up, retail investors were already moving toward energy stocks.
Keep Reading →
April 17 - Hedge Funds, News
Long-term wealth building requires choosing investments that could withstand various economic conditions.
Keep Reading →
March 27 - Hedge Funds, News
Is VRTX a good stock to buy? We came across a bullish thesis on Vertex Pharmaceuticals Incorporated on r/AIPortfolios by manojs.
Keep Reading →
March 24 - News, Stock Analysis
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best high profit margin stocks to buy.
Keep Reading →
March 24 - News
US equities fell on March 19, with oil prices falling as Wall Street awaited the latest news on the Iran conflict.
Keep Reading →
March 23 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the top gene therapy stocks to buy according to hedge funds.
Keep Reading →
February 28 - News
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
Keep Reading →
February 27 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best high growth high margin stocks to buy now.
Keep Reading →
February 13 - News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2025 Earnings Call Transcript February 12, 2026Vertex Pharmaceuticals Incorporated misses on earnings expectations.
Keep Reading →
February 13 - News, Transcripts
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is among the most profitable healthcare stocks to buy.
Keep Reading →
January 31 - News
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
Keep Reading →
January 30 - Hedge Funds, News
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the fourth quarter of 2025. ...
Keep Reading →
January 28 - Hedge Fund Investor Letters, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best future stocks to buy for the long term.
Keep Reading →
January 19 - News
On January 6, Dan Ives of Wedbush Securities joined 'Closing Bell' on CNBC to suggest that the tech bull market continues to play out.
Keep Reading →
January 16 - Hedge Funds, News
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded...
Keep Reading →
January 12 - Hedge Fund Investor Letters, News
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the third quarter of 2025. ...
Keep Reading →
December 29 - Hedge Fund Investor Letters, News
Harding Loevner, an asset management company, released its “Global Equity Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
December 4 - Hedge Fund Investor Letters, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best large cap stocks to invest in for the long term.
Keep Reading →
November 26 - News
Pies does not see anything fundamentally broken in today’s markets and stated that if we go through our checklist, we can see that a recession does not seem imminent.
Keep Reading →
November 25 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds.
Keep Reading →
November 18 - News
Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.
Keep Reading →
November 17 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q3 2025 Earnings Call Transcript November 3, 2025Vertex Pharmaceuticals Incorporated beats earnings expectations.
Keep Reading →
November 5 - News, Transcripts
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the most profitable biotech stocks to buy. H.C.
Keep Reading →
October 28 - News
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
Keep Reading →
October 27 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best long term low volatility stocks to buy right now.
Keep Reading →
October 22 - News
Mike Wilson, Morgan Stanley CIO and chief U.S.
Keep Reading →
October 22 - Hedge Funds, News
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter 2025 investor letter.
Keep Reading →
October 6 - Hedge Fund Investor Letters, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best biotech stocks to buy.
Keep Reading →
October 2 - News
The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.
Keep Reading →
September 30 - Hedge Funds, News
Loomis Sayles, an investment management company, released its “Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
September 3 - Hedge Fund Investor Letters, News
ClearBridge Investments, an investment management company, released its “ClearBridge All Cap Growth Strategy” second-quarter 2025 investor letter.
Keep Reading →
September 2 - Hedge Fund Investor Letters, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts.
Keep Reading →
August 18 - News
On August 16, FedWatch's Ben Emons joined CNBC Television for an interview to elaborate on his bull case that the all-time record highs are still to come.
Keep Reading →
August 17 - Hedge Funds, News
In a statement, Vertex Pharmaceuticals Inc.
Keep Reading →
August 6 - News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2025 Earnings Call Transcript August 4, 2025Vertex Pharmaceuticals Incorporated beats earnings expectations.
Keep Reading →
August 6 - News, Transcripts
We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts.
Keep Reading →
July 25 - News
The CEO of Pivotal Advisors, Tiffany McGhee, spoke on CNBC on June 27 on what investors should do in light of the current state of the market.
Keep Reading →
July 21 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks.
Keep Reading →
July 15 - News
The healthcare sector has been under pressure, underperforming the S&P 500 over the past several years.
Keep Reading →
July 14 - Hedge Funds, News
PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
July 8 - Hedge Fund Investor Letters, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best fundamental stocks to buy according to hedge funds. With a price target of $550, H.C.
Keep Reading →
June 29 - News